Company intelligence / Profile preview

Oxford Cancer Analytics

Oxford, England, United Kingdomoxcan.org ↗

Ownership: Private
Employees: ~30
Development stage: Preclinical

Overview

OXcan has developed a protein-based blood test using advanced proteomics and AI to detect early-stage lung cancer. The company’s approach has demonstrated improved outcomes over traditional DNA-based methods and leverages existing laboratory infrastructure for cost-effectiveness. Clinical deployment in the US is planned pending regulatory approval. The company collaborates with over 20 healthcare centers across three continents and holds ISO13485 certification status. No published pivotal trial results yet.

Therapeutic areas: Oncology
Modalities: Proteomics-based liquid biopsy (blood test)AI/machine learning-driven biomarker analysis
Industry: Protein Biomarker Diagnostics

Partnerships

Over 20 healthcare centers globally across three continents for technology development and deployment, including collaborations with Oxford University Hospitals NHS Foundation Trust and the Oxford Radcliffe Biobank.

Beyond the preview

Go deeper on Oxford Cancer Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Cancer Analytics.

Explore the full profile